Diatech Inc., Hafslund Nycomed AS deal

Hafslund's Nycomed Imaging subsidiary received a five-year option to an exclusive license for Europe and the Middle East, and an exclusive co-promotion agreement for the products in the U.S. using Diatech's peptide-based nuclear medicine imaging agents.

Hafslund (Oslo) will make a $10 million equity investment in privately held Diatech, and pay an undisclosed option fee, milestones and royalties. ...